Michael Mithoefer – MDMA and Psychotherapy – PESI

*** Proof of Product ***

---

Exploring the Essential Features of “Michael Mithoefer – MDMA and Psychotherapy – PESI”

MDMA and Psychotherapy
Speaker: Michael Mithoefer, MD
Duration: 2 Hours 59 Minutes
Format: Audio and Video

Description

For millennia, cultures around the world have embraced mind-altering substances to catalyze healing. Western psychotherapy has generally resisted the healing potential of such substances, but the FDA has lately approved clinical trials using MDMA—also known as Ecstasy, or Molly—to treat PTSD. Psychotherapists have a major role to play in these treatments, by helping clients process the healing shifts in consciousness that can occur on the drug.

Speaker

Michael Mithoefer, MD

Michael Mithoefer, MD, is clinical assistant professor of psychiatry at the Medical University of South Carolina. In 2009, he completed & published the first FDA approved clinical trial of MDMA assisted psychotherapy for treatment-resistant PTSD, followed by completion of a Phase II trial. He is overseeing a multisite Phase III study of MDMA-assisted psychotherapy in 13 sites around the US (including the Trauma Research Foundation), and another MDMA-assisted psychotherapy multisite study in Europe and Israel.

Speaker Disclosures:
Financial: Dr. Michael Mithoefer has employment relationships with Bassett Healthcare Network, Medical University of South Carolina, and MAPS Public Benefit Corporation. He has an ownership interest in Awakn Life Sciences and serves on the scientific advisory board. Dr. Mithoefer receives a speaking honorarium and recording royalties from PESI, Inc.
Non-financial: Dr. Michael Mithoefer is a fellow of the American Psychiatric Association.

Objectives

1. Explore specifics of the role therapists play in the healing process of MDMA-assisted psychotherapy, including balancing a non-directive approach with interventions based on the therapist’s training and intuition.
2. Explore what typically happens in the eight-hour therapy sessions that accompany the administering of MDMA.
3. Explore the history of MDMA and how its pharmacologic profile makes it effective against treatment resistant PTSD.
4. Identify the research processes used to determine the efficacy of MDMA and analyze the clinical impact on patients and quality of life after MDMA Assisted Psychotherapy in order to improve clinical outcomes with Post Traumatic Stress Disorder.

Outline

History of MDMA

• MDMA as Psychedelic
• MDMA Pharmacology
• MDMA Therapy Use in the 1970’s and 1980’s

Clinical Trials & Results

• Study Design
• Neuropsychology Measures
• Study with Veterans, Firefighters, & Police Officers
• Drug Treatment Development Protocol with Couples
• MDMA Therapy with Therapists
• MDMA Side Effects

Therapeutic Approach / MDMA in Psychotherapy

• Video Case Study
• Manual for MDMA Assisted Psychotherapy
• Why Does MDMA Work?
• Imaging
• MDMA Assisted Psychotherapy Agreements

The Future of MDMA Assisted Psychotherapy

• Further Research
• Expanded Access Clinics
• Training Program

Target Audience

• Psychologists
• Physicians
• Addiction Counselors
• Counselors
• Social Workers
• Marriage & Family Therapists
• Nurses
• Other Behavioral Health Professionals

Please see the full list of alternative group-buy courses available here: https://lunacourse.com/shop/